SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

From a Dirt Road to a Destination: A History of Franklin Street
In Chapel Hill, Franklin Street has been the main thoroughfare for decades and a must-see destination. When residents welcome guests to town, they take them...
Fri Apr 24, 2026

Carolina is calling Eric Church home
Country music superstar Eric Church has traveled the world performing songs for millions of fans. Through it all, one thing kept him connected to North...
Thu Apr 23, 2026

UNC earns top national rankings for graduate education
Numerous UNC graduate programs received high rankings in the U.S. News & World Report’s “Best Graduate Schools” list, with 20 placing among the top 10...
Wed Apr 22, 2026

Savannah Bananas take on the Texas Tailgaters — and take over Chapel Hill
As early as Monday, April 6, a navy tractor trailer adorned with a bright yellow banana holding a bat screeched to a halt onto the...
Tue Apr 21, 2026